サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1777785

抗菌薬耐性サーベイランスの世界市場

Antimicrobial Resistance Surveillance

出版日
ページ情報
英文 377 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
抗菌薬耐性サーベイランスの世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 377 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗菌薬耐性サーベイランスの世界市場は2030年までに79億米ドルに到達

2024年に61億米ドルと推定される抗菌薬耐性サーベイランスの世界市場は、分析期間2024-2030年にCAGR 4.6%で成長し、2030年には79億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断キットは、CAGR 5.3％を記録し、分析期間終了までに40億米ドルに達すると予測されます。診断システム分野の成長率は、分析期間中CAGR 4.3％と推定されます。

米国市場は16億米ドル、中国はCAGR 8.4％で成長予測

米国の抗菌薬耐性サーベイランス市場は2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに17億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8％と3.6％と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界の抗菌薬耐性サーベイランス市場- 主要動向と促進要因のまとめ

スーパーバグの脅威の高まりはAMRサーベイランスをどのように形成しているか？

抗菌薬耐性（AMR）は世界の公衆衛生の危機であり、薬剤耐性感染を放置すると2050年までに年間1,000万人が死亡すると予測されています。多剤耐性（MDR）細菌、真菌、ウイルス、寄生虫の増加により、世界中で強固なAMRサーベイランスシステムの需要が加速しています。政府、ヘルスケア機関、製薬会社は、耐性パターンを追跡し緩和するために、早期発見メカニズム、ゲノム配列決定、リアルタイムデータ解析に投資しています。世界保健機関（WHO）の世界抗菌薬耐性・使用監視システム（Global Antimicrobial Resistance and Use Surveillance System、GLASS）は、各国における監視アプローチの標準化において極めて重要な役割を果たしてきました。しかし、低資源国の多くは、データ収集、検査インフラ、診断能力において依然として課題に直面しており、AMRの追跡を強化するために、モバイルベースやAIを活用した革新的なソリューションが必要とされています。

最先端テクノロジーはAMRサーベイランスを再定義できるか？

次世代シーケンサー（NGS）、機械学習アルゴリズム、ビッグデータ解析の急速な進歩はAMRサーベイランスに革命をもたらし、耐性病原体をより迅速かつ正確に特定できるようになりました。AIを活用した予測モデルは現在、電子カルテ（EHR）と統合され、AMRの動向をリアルタイムで追跡できるようになり、臨床医が十分な情報に基づき治療方針を決定するのに役立っています。さらに、ポイントオブケア診断とウェアラブルバイオセンサーは、臨床と地域社会の両方の環境において、早期の耐性検出を向上させています。クラウドベースのプラットフォームは、世界のデータ共有を可能にし、国際的な協力関係を促進し、AMRアウトブレイクに対する備えを強化します。AMRデータ管理にブロックチェーン技術を導入することで、透明性と信頼性が向上し、抗菌薬使用量と耐性菌の進化を正確に追跡できるようになります。

AMRサーベイランスの全地域への拡大における課題とは？

進歩にもかかわらず、いくつかの障壁がAMRサーベイランスの世界の拡大を妨げています。特に中低所得国（LMICs）では、限られた資金、熟練した人材の不足、規制の格差が依然として大きな課題となっています。さらに、市販の抗生物質の販売、セルフメディケーションの実践、不十分な病院感染管理政策が、耐性菌の無言の蔓延を助長し、サーベイランス活動をより複雑なものにしています。家畜や食品のサプライチェーンにおける人獣共通感染症（AMR）病原体の存在感の高まりは、ヒト、動物、環境のサーベイランスを統合した、より強力なワンヘルス・アプローチを要求しています。世界規模でAMRに効果的に取り組むためには、統一された報告基準、リアルタイムのデータアクセス、政府機関と民間医療機関の協力体制を確保することが不可欠です。

抗菌薬耐性サーベイランス市場の成長を後押ししているのは？

抗菌薬耐性サーベイランス市場の成長は、薬剤耐性感染症の負担増加、ゲノムシーケンス技術の採用増加、政府主導のサーベイランスイニシアチブなど、いくつかの要因によってもたらされます。製薬業界はコンパニオン診断や耐性プロファイリングツールに積極的に投資しており、次世代抗生物質や代替療法の開発を促進しています。AIを統合した監視プラットフォーム、予測分析、ブロックチェーンベースの追跡システムに対する需要の高まりは、市場の拡大をさらに後押ししています。さらに、抗生物質スチュワードシップ・プログラムとリアルタイムのAMR報告を義務付ける厳しい規制ガイドラインが、監視インフラへの投資を促進しています。精密医療、迅速診断検査、ワンヘルス・フレームワークへの注目の高まりは、AMRサーベイランス市場を引き続き牽引し、抗菌薬耐性との世界の闘いの礎石として位置づけると思われます。

セグメント

ソリューション（診断キット、診断システム、診断ソフトウェア、診断サービス）、用途（臨床診断用途、公衆衛生サーベイランス用途、検査室サーベイランス用途）、最終用途（病院、診療所、その他最終用途）

調査対象企業の例

  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cepheid
  • Diasorin S.P.A.
  • Liofilchem S.r.l.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Qiagen NV

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29187

Global Antimicrobial Resistance Surveillance Market to Reach US$7.9 Billion by 2030

The global market for Antimicrobial Resistance Surveillance estimated at US$6.1 Billion in the year 2024, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Diagnostic Kits, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Diagnostic Systems segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 8.4% CAGR

The Antimicrobial Resistance Surveillance market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Antimicrobial Resistance Surveillance Market - Key Trends & Drivers Summarized

How Is the Growing Threat of Superbugs Shaping AMR Surveillance?

Antimicrobial resistance (AMR) is a global public health crisis, with drug-resistant infections projected to cause 10 million deaths annually by 2050 if left unchecked. The increasing prevalence of multi-drug resistant (MDR) bacteria, fungi, viruses, and parasites has accelerated the demand for robust AMR surveillance systems worldwide. Governments, healthcare institutions, and pharmaceutical companies are investing in early detection mechanisms, genome sequencing, and real-time data analytics to track and mitigate resistance patterns. The World Health Organization’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) has been pivotal in standardizing surveillance approaches across nations. However, many low-resource countries still face challenges in data collection, laboratory infrastructure, and diagnostic capabilities, necessitating innovative mobile-based and AI-powered solutions to enhance AMR tracking.

Can Cutting-Edge Technologies Redefine AMR Surveillance?

The rapid advancements in next-generation sequencing (NGS), machine learning algorithms, and big data analytics have revolutionized AMR surveillance, allowing for faster and more precise identification of resistant pathogens. AI-driven predictive models are now being integrated with electronic health records (EHRs) to track AMR trends in real-time, helping clinicians make informed treatment decisions. Moreover, point-of-care diagnostics and wearable biosensors are improving early resistance detection in both clinical and community settings. Cloud-based platforms enable global data sharing, fostering international collaborations and reinforcing preparedness against AMR outbreaks. The introduction of blockchain technology in AMR data management is also enhancing transparency and reliability, ensuring accurate tracking of antimicrobial usage and resistance evolution.

What Are the Challenges in Expanding AMR Surveillance to All Regions?

Despite advancements, several barriers hinder the global expansion of AMR surveillance. Limited funding, lack of skilled personnel, and regulatory disparities remain major challenges, particularly in low- and middle-income countries (LMICs). Additionally, over-the-counter antibiotic sales, self-medication practices, and poor hospital infection control policies contribute to the silent spread of resistance, making surveillance efforts more complex. The growing presence of zoonotic AMR pathogens in livestock and food supply chains demands stronger One Health approaches, integrating human, animal, and environmental surveillance under a unified system. Ensuring uniform reporting standards, real-time data access, and collaboration between government agencies and private healthcare providers is imperative for tackling AMR effectively on a global scale.

What’s Fueling the Growth of the Antimicrobial Resistance Surveillance Market?

The growth in the antimicrobial resistance surveillance market is driven by several factors, including the rising burden of drug-resistant infections, increasing adoption of genomic sequencing technologies, and government-led surveillance initiatives. The pharmaceutical industry is actively investing in companion diagnostics and resistance profiling tools, fostering the development of next-generation antibiotics and alternative therapies. The increasing demand for AI-integrated surveillance platforms, predictive analytics, and blockchain-based tracking systems is further bolstering market expansion. Moreover, stringent regulatory guidelines mandating antibiotic stewardship programs and real-time AMR reporting are propelling investments in surveillance infrastructure. The growing focus on precision medicine, rapid diagnostic tests, and One Health frameworks will continue to drive the AMR surveillance market, positioning it as a cornerstone in the global fight against antimicrobial resistance.

SCOPE OF STUDY:

The report analyzes the Antimicrobial Resistance Surveillance market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Solution (Diagnostic Kits, Diagnostic Systems, Diagnostics Software, Diagnostic Services); Application (Clinical Diagnostics Application, Public Health Surveillance Application, Laboratory Surveillance Application); End-Use (Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cepheid
  • Diasorin S.P.A.
  • Liofilchem S.r.l.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Qiagen NV

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Antimicrobial Resistance Surveillance - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Consumer Preference for Age-Defying Grooming Solutions
    • Rising Popularity of Natural & Organic Hair Pigmentation Solutions
    • Advancements in Peptide-Based Melanin-Stimulating Compounds
    • Increasing Adoption of Herbal & Ayurvedic Anti-Graying Products
    • Expanding Male Grooming Market Fueling Demand for Beard Care Innovations
    • Technological Innovations in Long-Lasting Hair Pigmentation Solutions
    • Growing Demand for Personalized Anti-Graying Formulations
    • Influence of Social Media & Celebrity Endorsements on Product Adoption
    • Increasing Availability of Non-Invasive & Topical Anti-Graying Solutions
    • Rising Consumer Awareness About Scalp Health & Hair Follicle Longevity
    • Surging Investments in Dermatological Research for Hair Aging Reversal
    • E-commerce Expansion Driving Market Accessibility & Product Innovation
    • Emergence of Hybrid Hair Care Solutions Combining Anti-Graying & Hair Strengthening Properties
    • Sustainability & Eco-Friendly Packaging Trends Shaping Product Preferences
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Antimicrobial Resistance Surveillance Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Diagnostics Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Public Health Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Public Health Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Public Health Surveillance Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Laboratory Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Laboratory Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Laboratory Surveillance Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • CHINA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • INDIA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030

IV. COMPETITION